Green tea halts progression of cardiac transthyretin amyloidosis: an observational report

Background: Treatment options in patients with amyloidotic transthyretin (ATTR) cardiomyopathy are limited. Epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea (GT), inhibits fibril formation from several amyloidogenic proteins in vitro. Thus, it might also halt progression of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kristen, Arnt (VerfasserIn) , Lehrke, Stephanie (VerfasserIn) , Buß, Sebastian Johannes (VerfasserIn) , Mereles, Derliz (VerfasserIn) , Steen, Henning (VerfasserIn) , Ehlermann, Philipp (VerfasserIn) , Hardt, Stefan (VerfasserIn) , Giannitsis, Evangelos (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Schnabel, Philipp Albert (VerfasserIn) , Dengler, Thomas (VerfasserIn) , Katus, Hugo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012
In: Clinical research in cardiology
Year: 2012, Jahrgang: 101, Heft: 10, Pages: 805-813
ISSN:1861-0692
DOI:10.1007/s00392-012-0463-z
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1007/s00392-012-0463-z
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00392-012-0463-z
Volltext
Verfasserangaben:Arnt V. Kristen, Stephanie Lehrke, Sebastian Buss, Derliz Mereles, Henning Steen, Philipp Ehlermann, Stefan Hardt, Evangelos Giannitsis, Rupert Schreiner, Uwe Haberkorn, Philipp A. Schnabel, Reinhold P. Linke, Christoph Röcken, Erich E. Wanker, Thomas J. Dengler, Klaus Altland, Hugo A. Katus

MARC

LEADER 00000caa a2200000 c 4500
001 157685289X
003 DE-627
005 20220814174422.0
007 cr uuu---uuuuu
008 180626s2012 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00392-012-0463-z  |2 doi 
035 |a (DE-627)157685289X 
035 |a (DE-576)50685289X 
035 |a (DE-599)BSZ50685289X 
035 |a (OCoLC)1341012813 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kristen, Arnt  |d 1974-  |e VerfasserIn  |0 (DE-588)123480965  |0 (DE-627)706314530  |0 (DE-576)293726876  |4 aut 
245 1 0 |a Green tea halts progression of cardiac transthyretin amyloidosis  |b an observational report  |c Arnt V. Kristen, Stephanie Lehrke, Sebastian Buss, Derliz Mereles, Henning Steen, Philipp Ehlermann, Stefan Hardt, Evangelos Giannitsis, Rupert Schreiner, Uwe Haberkorn, Philipp A. Schnabel, Reinhold P. Linke, Christoph Röcken, Erich E. Wanker, Thomas J. Dengler, Klaus Altland, Hugo A. Katus 
264 1 |c 2012 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 15 May 2012 
500 |a Gesehen am 26.06.2018 
520 |a Background: Treatment options in patients with amyloidotic transthyretin (ATTR) cardiomyopathy are limited. Epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea (GT), inhibits fibril formation from several amyloidogenic proteins in vitro. Thus, it might also halt progression of TTR amyloidosis. This is a single-center observational report on the effects of GT consumption in patients with ATTR cardiomopathy. Methods: 19 patients with ATTR cardiomyopathy were evaluated by standard blood tests, echocardiography, and cardiac MRI (n = 9) before and after consumption of GT and/or green tea extracts (GTE) for 12 months. Results: Five patients were not followed up for reasons of death (n = 2), discontinuation of GT/GTE consumption (n = 2), and heart transplantation (n = 1). After 12 months no increase of left ventricular (LV) wall thickness and LV myocardial mass was observed by echocardiography. In the subgroup of patients evaluated by cardiac MRI a mean decrease of LV myocardial mass (−12.5 %) was detected in all patients. This was accompanied by an increase of mean mitral annular systolic velocity of 9 % in all 14 patients. Total cholesterol (191.9 ± 8.9 vs. 172.7 ± 9.4 mg/dL; p < 0.01) and LDL cholesterol (105.8 ± 7.6 vs. 89.5 ± 8.0 mg/dL; p < 0.01) decreased significantly during the observational period. No serious adverse effects were reported by any of the participants. Conclusions: Our observation suggests an inhibitory effect of GT and/or GTE on the progression of cardiac amyloidosis. We propose a randomized placebo-controlled investigation to confirm our observation. 
700 1 |a Lehrke, Stephanie  |d 1976-  |e VerfasserIn  |0 (DE-588)123769175  |0 (DE-627)706420756  |0 (DE-576)29387008X  |4 aut 
700 1 |a Buß, Sebastian Johannes  |d 1977-  |e VerfasserIn  |0 (DE-588)131490451  |0 (DE-627)509814050  |0 (DE-576)298541963  |4 aut 
700 1 |a Mereles, Derliz  |d 1963-  |e VerfasserIn  |0 (DE-588)129031062  |0 (DE-627)387883754  |0 (DE-576)297456970  |4 aut 
700 1 |a Steen, Henning  |d 1972-  |e VerfasserIn  |0 (DE-588)123681669  |0 (DE-627)706393600  |0 (DE-576)293824851  |4 aut 
700 1 |a Ehlermann, Philipp  |d 1969-  |e VerfasserIn  |0 (DE-588)121563812  |0 (DE-627)705540855  |0 (DE-576)292774761  |4 aut 
700 1 |a Hardt, Stefan  |e VerfasserIn  |0 (DE-588)1028380585  |0 (DE-627)730637611  |0 (DE-576)375919309  |4 aut 
700 1 |a Giannitsis, Evangelos  |e VerfasserIn  |0 (DE-588)113336241  |0 (DE-627)577184091  |0 (DE-576)289759579  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Schnabel, Philipp Albert  |d 1953-2021  |e VerfasserIn  |0 (DE-588)102254960X  |0 (DE-627)717000087  |0 (DE-576)16982750X  |4 aut 
700 1 |a Dengler, Thomas  |e VerfasserIn  |0 (DE-588)1077763050  |0 (DE-627)837469198  |0 (DE-576)184645417  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
773 0 8 |i Enthalten in  |t Clinical research in cardiology  |d Berlin : Springer, 2006  |g 101(2012), 10, Seite 805-813  |h Online-Ressource  |w (DE-627)506287343  |w (DE-600)2218331-0  |w (DE-576)251097692  |x 1861-0692  |7 nnas  |a Green tea halts progression of cardiac transthyretin amyloidosis an observational report 
773 1 8 |g volume:101  |g year:2012  |g number:10  |g pages:805-813  |g extent:9  |a Green tea halts progression of cardiac transthyretin amyloidosis an observational report 
856 4 0 |u http://dx.doi.org/10.1007/s00392-012-0463-z  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00392-012-0463-z  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180626 
993 |a Article 
994 |a 2012 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 17  |y j 
998 |g 1077763050  |a Dengler, Thomas  |m 1077763050:Dengler, Thomas  |d 50000  |e 50000PD1077763050  |k 0/50000/  |p 15 
998 |g 102254960X  |a Schnabel, Philipp Albert  |m 102254960X:Schnabel, Philipp Albert  |d 910000  |d 912000  |e 910000PS102254960X  |e 912000PS102254960X  |k 0/910000/  |k 1/910000/912000/  |p 11 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 60000  |d 62900  |e 60000PH1022913905  |e 62900PH1022913905  |k 0/60000/  |k 1/60000/62900/  |p 10 
998 |g 113336241  |a Giannitsis, Evangelos  |m 113336241:Giannitsis, Evangelos  |d 910000  |d 910100  |e 910000PG113336241  |e 910100PG113336241  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1028380585  |a Hardt, Stefan  |m 1028380585:Hardt, Stefan  |d 50000  |e 50000PH1028380585  |k 0/50000/  |p 7 
998 |g 121563812  |a Ehlermann, Philipp  |m 121563812:Ehlermann, Philipp  |d 910000  |d 910100  |e 910000PE121563812  |e 910100PE121563812  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 123681669  |a Steen, Henning  |m 123681669:Steen, Henning  |d 50000  |e 50000PS123681669  |k 0/50000/  |p 5 
998 |g 129031062  |a Mereles, Derliz  |m 129031062:Mereles, Derliz  |d 910000  |d 910100  |e 910000PM129031062  |e 910100PM129031062  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 131490451  |a Buß, Sebastian Johannes  |m 131490451:Buß, Sebastian Johannes  |d 910000  |d 910100  |e 910000PB131490451  |e 910100PB131490451  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 123769175  |a Lehrke, Stephanie  |m 123769175:Lehrke, Stephanie  |d 910000  |d 910100  |e 910000PL123769175  |e 910100PL123769175  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 123480965  |a Kristen, Arnt  |m 123480965:Kristen, Arnt  |d 910000  |d 910100  |e 910000PK123480965  |e 910100PK123480965  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN157685289X  |e 3013806079 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Published online: 15 May 2012","Gesehen am 26.06.2018"],"person":[{"role":"aut","family":"Kristen","display":"Kristen, Arnt","given":"Arnt"},{"family":"Lehrke","role":"aut","given":"Stephanie","display":"Lehrke, Stephanie"},{"family":"Buß","role":"aut","given":"Sebastian Johannes","display":"Buß, Sebastian Johannes"},{"role":"aut","family":"Mereles","given":"Derliz","display":"Mereles, Derliz"},{"role":"aut","family":"Steen","given":"Henning","display":"Steen, Henning"},{"given":"Philipp","display":"Ehlermann, Philipp","family":"Ehlermann","role":"aut"},{"family":"Hardt","role":"aut","display":"Hardt, Stefan","given":"Stefan"},{"family":"Giannitsis","role":"aut","display":"Giannitsis, Evangelos","given":"Evangelos"},{"family":"Haberkorn","role":"aut","given":"Uwe","display":"Haberkorn, Uwe"},{"role":"aut","family":"Schnabel","given":"Philipp Albert","display":"Schnabel, Philipp Albert"},{"display":"Dengler, Thomas","given":"Thomas","family":"Dengler","role":"aut"},{"role":"aut","family":"Katus","given":"Hugo","display":"Katus, Hugo"}],"recId":"157685289X","language":["eng"],"name":{"displayForm":["Arnt V. Kristen, Stephanie Lehrke, Sebastian Buss, Derliz Mereles, Henning Steen, Philipp Ehlermann, Stefan Hardt, Evangelos Giannitsis, Rupert Schreiner, Uwe Haberkorn, Philipp A. Schnabel, Reinhold P. Linke, Christoph Röcken, Erich E. Wanker, Thomas J. Dengler, Klaus Altland, Hugo A. Katus"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"relHost":[{"origin":[{"publisher":"Springer","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisherPlace":"Berlin"}],"title":[{"title_sort":"Clinical research in cardiology","title":"Clinical research in cardiology"}],"disp":"Green tea halts progression of cardiac transthyretin amyloidosis an observational reportClinical research in cardiology","type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2218331-0"],"issn":["1861-0692"],"eki":["506287343"]},"recId":"506287343","pubHistory":["95.2006 -"],"language":["eng"],"part":{"text":"101(2012), 10, Seite 805-813","issue":"10","extent":"9","pages":"805-813","year":"2012","volume":"101"}}],"id":{"eki":["157685289X"],"doi":["10.1007/s00392-012-0463-z"]},"physDesc":[{"extent":"9 S."}],"title":[{"title":"Green tea halts progression of cardiac transthyretin amyloidosis","subtitle":"an observational report","title_sort":"Green tea halts progression of cardiac transthyretin amyloidosis"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a KRISTENARNGREENTEAHA2012